Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Resistance”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT06745804
What this trial is testing

Study of 68Ga-R10602

Who this might be right for
Locoregionally Recurrent Hormone-receptor Positive Breast CancerMetastatic Hormone Receptor Positive Breast CancerHormone Receptor Positive Breast Adenocarcinoma
Radionetics Oncology 27
Testing effectiveness (Phase 2)Looking for participantsNCT05310643
What this trial is testing

Nivolumab and Ipilimumab in Anti-PD1-Resistant dMMR/MSI mCRC

Who this might be right for
Metastatic Colorectal Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 30
Not applicableStudy completedNCT03728725
What this trial is testing

Xpert MTB/XDR Clinical Evaluation Trial

Who this might be right for
Tuberculosis, PulmonaryTuberculosis, Multidrug-Resistant
Foundation for Innovative New Diagnostics, Switzerland 710
Early research (Phase 1)Active Not RecruitingNCT05245006
What this trial is testing

PET Imaging Study of 89Zr-DFO-YS5 in Men With Prostate Cancer

Who this might be right for
Prostate CancerMetastatic Castration-resistant Prostate Cancer
Robert Flavell, MD, PhD 30
Testing effectiveness (Phase 2)Study completedNCT06076135
What this trial is testing

Intestinal Low Dose Radiotherapy Combined With Immunotherapy in Immune-resistant Metastatic Solid Tumors

Who this might be right for
Metastatic Malignant Solid NeoplasmRadiotherapyImmune Checkpoint Blockade+1 more
Chuangzhen Chen 24
Early research (Phase 1)UnknownNCT05222009
What this trial is testing

G-CSF in Patients With Anti-PD-1-axis Therapy-resistant Recurrent or Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Granulocyte Colony-Stimulating FactorPD-1 Inhibitor
Sun Yat-sen University 25
Not applicableLooking for participantsNCT07050433
What this trial is testing

COMPASS Study for Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Duke University 48
Testing effectiveness (Phase 2)Looking for participantsNCT07832292
What this trial is testing

JNJ-101556143 in Participants With Metastatic Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Janssen Research & Development, LLC 100
Testing effectiveness (Phase 2)WithdrawnNCT02966587
What this trial is testing

Durvalumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Who this might be right for
Castration Levels of TestosteroneHormone-Resistant Prostate CancerMicrosatellite Instability
University of Washington
Testing effectiveness (Phase 2)Study completedNCT01447706
What this trial is testing

MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers

Who this might be right for
Epithelial Ovarian CancerFallopian Tube CancerPeritoneal Cancer
Merrimack Pharmaceuticals 223
Post-approval studies (Phase 4)UnknownNCT03432949
What this trial is testing

Radium-223 Combined With Dexamethasone as First-line Therapy in Patients With M+CRPC

Who this might be right for
Metastatic Prostate Cancer
University Health Network, Toronto 24
Testing effectiveness (Phase 2)Study completedNCT00061126
What this trial is testing

ABX-EGF (a Monoclonal Antibody) Given to Patients With Prostate Cancer With or Without Tumor in Other Parts of the Body

Who this might be right for
Prostate Cancer
Abgenix 50
Testing effectiveness (Phase 2)Ended earlyNCT05489991
What this trial is testing

TmPSMA-02 Chimeric Antigen Receptor (CAR) T-cells in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Tceleron Therapeutics, Inc. 1
Testing effectiveness (Phase 2)Looking for participantsNCT06610825
What this trial is testing

Castrate Resistant Prostate Cancer Enhertu Therapy

Who this might be right for
Prostate Cancer MetastaticProstate CancerCRPC
Washington D.C. Veterans Affairs Medical Center 60
Testing effectiveness (Phase 2)Looking for participantsNCT05563558
What this trial is testing

Pembrolizumab, Carboplatin and Cabazitaxel in Aggressive Metastatic Castration Resistant Prostate Cancer (PEAPOD_FOS)

Who this might be right for
Prostate Cancer Metastatic
Fundacion Oncosur 42
Testing effectiveness (Phase 2)Looking for participantsNCT04868604
What this trial is testing

64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Clarity Pharmaceuticals Ltd 54
Testing effectiveness (Phase 2)Study completedNCT03159143
What this trial is testing

Study of Docetaxel and Oxaliplatin in Metastatic Transitional Cell Cancer (TCC) of the Urothelial Tract

Who this might be right for
Metastatic Transitional Cell Cancer of the Urothelial Tract
Leonard Appleman 22
Early research (Phase 1)Study completedNCT03778047
What this trial is testing

A Study Evaluating Enzalutamide Pharmacokinetics and Pharmacodynamics, and Related Changes After Drug Switch

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Hinova Pharmaceuticals Inc. 10
Large-scale testing (Phase 3)Not Yet RecruitingNCT07641855
What this trial is testing

BL-B01D1 Combination Therapy in Patients With Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Castration-resistant Prostate Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 180
Testing effectiveness (Phase 2)Study completedNCT01929655
What this trial is testing

Japanese BAY88-8223 Monotherapy Phase II Study

Who this might be right for
Prostatic Neoplasms
Bayer 49
Next Page